The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite

Atsuhiro Sugidachi, Taketoshi Ogawa(Biomedical Research Laboratories (United States)), Atsushi Kurihara(Daiichi-Sankyo (Japan)), Katsunobu Hagihara(Daiichi-Sankyo (Japan)), Joseph A. Jakubowski(Eli Lilly (United States)), Masami Hashimoto(Biomedical Research Laboratories (United States)), Y. Niitsu(Biomedical Research Laboratories (United States)), Fumitoshi Asai(Eli Lilly (United States))
Journal of Thrombosis and Haemostasis
June 19, 2007
10.1111/j.1538-7836.2007.02598.x
Cited by 218Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis